Table 2 Baseline clinical characteristics of patients stratified by major adverse cardiovascular events
Characteristic | Non-MACE (n = 745) | MACE (n = 214) | P value |
|---|---|---|---|
Age, mean (SD), years | 61.2 (10.6) | 63.9 (9.9) | 0.001 |
Male, No. (%) | 556 (74.6) | 159 (74.3) | 0.993 |
SBP, mean (SD), mmHg | 143.5 (25.0) | 134.9 (23.9) |  < 0.001 |
DBP, mean (SD), mmHg | 79.8 (13.5) | 74.9 (12.5) |  < 0.001 |
Heart rate, mean (SD), beats/min | 79.9 (14.4) | 82.4 (15.6) | 0.026 |
Medical history and risk factors, No. (%) | Â | Â | |
 Hypertension | 689 (92.5) | 201 (93.9) | 0.569 |
 Diabetes mellitus | 380 (51.0) | 129 (60.3) | 0.020 |
 Current smoker | 142 (19.1) | 39 (18.2) | 0.860 |
 Atrial fibrillation | 55 (7.4) | 26 (12.1) | 0.038 |
 Cerebrovascular disease | 133 (17.9) | 51 (23.8) | 0.063 |
 Valvular disease | 22 (3.0) | 9 (4.2) | 0.488 |
 Peripheral arterial disease | 70 (9.4) | 25 (11.7) | 0.391 |
Cause of ESRD, No. (%) | Â | Â | 0.077 |
 Diabetes mellitus | 226 (30.3) | 78 (36.4) |  |
 Hypertension | 91 (12.2) | 32 (15.0) |  |
 Glomerulonephritis | 191 (25.6) | 39 (18.2) |  |
 Other/unknown | 237 (31.8) | 65 (30.4) |  |
Insulin therapy, No. (%) | 246 (33.0) | 76 (35.5) | 0.549 |
Dialysis modality, No. (%) | Â | Â | 1.000 |
 Hemodialysis | 689 (92.5) | 198 (92.5) |  |
 Peritoneal dialysis | 56 (7.5) | 16 (7.5) |  |
Vintage, years | Â | Â | 0.331 |
 < 1 | 162 (21.7) | 37 (17.3) |  |
 1–5 | 337 (45.2) | 107 (50.0) |  |
 5–10 | 190 (25.5) | 58 (27.1) |  |
 ≥ 10 | 56 (7.5) | 12 (5.6) |  |
Index presentation, No. (%) |  |  |  < 0.001 |
 AMI | 413 (55.4) | 151 (70.6) |  |
 Non-AMI | 332 (44.6) | 63 (29.4) |  |
Hemoglobin, g/L | 105.3 (19.9) | 105.9 (19.5) | 0.696 |
Glucose, mmol/L | 6.0 [4.7, 8.7] | 7.9 [5.7, 10.6] |  < 0.001 |
Serum creatinine, mg/dl | 8.7 [6.7, 10.9] | 8.4 [6.7, 10.9] | 0.416 |
TG, mmol/L | 1.6 [1.1, 2.3] | 1.6 [1.1, 2.3] | 0.585 |
TC, mmol/L | 3.7 [3.1, 4.5] | 3.8 [3.1, 4.4] | 0.854 |
HDL-C, mmol/L | 0.9 [0.7, 1.1] | 0.9 [0.7, 1.1] | 0.204 |
LDL-C, mmol/L | 2.2 [1.6, 2.8] | 2.1 [1.7, 2.8] | 0.894 |
TyG index | 9.0 [8.5, 9.5] | 9.3 [8.8, 9.8] |  < 0.001 |
Procedure characteristic, No. (%) | Â | Â | Â |
 Radial access | 578 (77.6) | 162 (75.7) | 0.627 |
 Extent of disease |  |  |  |
  Any left main disease | 67 (9.0) | 44 (20.6) |  < 0.001 |
  2-vessel disease | 216 (29.0) | 47 (22.0) | 0.052 |
  3-vessel disease | 391 (52.5) | 153 (71.5) |  < 0.001 |
 Moderate or severe calcification | 324 (43.5) | 108 (50.5) | 0.084 |
 PCI treatment | 535 (71.8) | 141 (65.9) | 0.112 |
Discharge medications, No. (%) | Â | Â | Â |
 Dual antiplatelet therapy | 642 (86.2) | 194 (90.7) | 0.107 |
 ACE inhibitor or ARB | 357 (47.9) | 84 (39.3) | 0.030 |
 Beta-blocker | 597 (80.1) | 178 (83.2) | 0.369 |
 Calcium-channel blocker | 500 (67.1) | 120 (56.1) | 0.004 |
 Statin | 697 (93.6) | 202 (94.4) | 0.776 |